A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Cryoablation Combined With Tislelizumab Plus Lenvatinib in 1L Treatment of Advanced HCC (CASTLE-10)
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate Lenvatinib Plus Tislelizumab for Locally Advanced Unresectable or Metastatic Hepatocellular Carcinoma With Hepatitis B Virus Infection and Biomarker Analyses
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Goal-directed LCVP Based on HP in Laparoscopic Hepatectomy
- Status
- RECRUITING
- Phase
- NA
Effects of Vitamin D Status and Multiple Mega-dose Supplementation on Health Care Disparities in Perioperative Patients With Hepatocellular Carcinoma Receiving Hepatectomy
- Status
- NOT_YET_RECRUITING
- Phase
- NA
HAIC Plus A+T for Patients With High-risk HCC: a Single-arm Phase 2 Trial
- Status
- UNKNOWN
- Phase
- PHASE2
Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T
- Status
- WITHDRAWN
- Phase
- PHASE2
TIPS Plus Cadonilimab in Advanced HCC with Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Phase II Study
- Status
- RECRUITING
- Phase
- PHASE2
The ImmunoXXL Study
- Status
- UNKNOWN
- Phase
- N/A
HOPE to Reduce Tumour Recurrence After LT In Patients With HCC
- Status
- UNKNOWN
- Phase
- NA
M-TACE Treatment for Unresectable Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- NA
18F-FDGal PET/CT and PET/MRI in Patients With Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- NA
Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- N/A
HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE3
PM8002 in Combination With Chemotherapy as First Line Therapy in Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.
- Status
- RECRUITING
- Phase
- PHASE3
Navigating the Clinical Trial Process for Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients
- Status
- RECRUITING
- Phase
- PHASE2
Lenvatinib Plus Tislelizumab With or Without TACE in First-line Treatment of Unresectable HCC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2